Ronald Castelino | Nephrology | Best Researcher Award

Assoc. Prof. Dr. Ronald Castelino | Nephrology | Best Researcher Award

Head of Pharmacy Practice, University of Sydney, Australia

Ronald L. Castelino, BPharm, MPharm, PhD, PDCR, MSHPA, is an Associate Professor in Pharmacology & Clinical Pharmacy at the University of Sydney and an Adjunct Senior Lecturer at the University of Tasmania. With a strong academic foundation and global experience in clinical pharmacy, especially nephrology, he focuses on the quality use of medicines in chronic diseases. His academic journey spans India and Australia, backed by leadership in teaching and translational research. He contributes extensively to nursing and pharmacy education while holding an active pharmacist role at Blacktown Hospital. Dr. Castelino has co-supervised multiple postgraduate research projects, published over 90 papers, and leads a research group focused on kidney disease management and medication safety. He is Board Certified in Geriatric Pharmacy and a Fellow of the Australia and New Zealand College of Advanced Pharmacy. A passionate educator, clinician, and researcher, he embodies a multidisciplinary approach to advancing pharmacy practice and patient-centered care.

Profile

๐ŸŽ“ Education

Dr. Ronald Castelino holds a PhD in Pharmacy Practice from the University of Sydney (2011), an MPharm in Pharmacy Practice (2006), and a BPharm (2003) from Rajiv Gandhi University of Health Sciences, Bangalore, India. He also completed a Professional Diploma in Clinical Research (PDCR, 2006) and is Board Certified in Geriatric Pharmacy (BCGP, 2018). In 2024, he was honored as a Fellow of the Australia and New Zealand College of Advanced Pharmacy (FANZCAP) for his contributions to nephrology and research. His educational achievements are distinguished with high academic honors, including a Gold Medal and Second Rank in his MPharm degree. This diverse educational background underpins his extensive work in clinical pharmacology, research methodology, and teaching. His academic preparation reflects a balance of clinical training, research competence, and leadership in the pharmaceutical sciences. These qualifications have enabled him to impact pharmacy education and practice across undergraduate, postgraduate, and professional levels.

๐Ÿงช Experience

Dr. Castelino has held progressive academic and clinical roles across India and Australia. He is currently Associate Professor at the University of Sydney (since 2023) and previously served as Senior Lecturer (2016โ€“2022) and Lecturer at the University of Tasmania (2011โ€“2016). His clinical experience includes roles as Renal Pharmacist at Blacktown Hospital (NSW, since 2016), Pharmacist at Calvary Health Care Tasmania (2012โ€“2015), Clinical Educator at Royal Hobart Hospital, and Clinical Pharmacist in India (2004โ€“2007). He has tutored at the University of Sydney (2008โ€“2011) and coordinated various undergraduate and postgraduate subjects in pharmacy and nursing, including pharmacology, therapeutics, and evidence-based practice. Dr. Castelino has also served on scientific committees and has been instrumental in supervising PhD and MPhil candidates. His dual expertise in clinical pharmacy and academia supports a translational approach to patient care and education, positioning him as a bridge between hospital practice and academic advancement in medication safety and chronic disease management.

๐Ÿ… Awards and Honors

Dr. Ronald Castelino has received numerous accolades throughout his academic and professional career. He was awarded the Teaching Merit Certificate by the University of Tasmania in both 2013 and 2014 for excellence in education. His outstanding academic performance was recognized with the Second Rank in MPharm (Pharmacy Practice) by Rajiv Gandhi University of Health Sciences, Bangalore, India (2006). He was also the Gold Medallist and Best Outgoing Student at JSS College of Pharmacy, Mysore (2004โ€“2005). In recognition of his expertise and leadership in nephrology and pharmacy research, he became a Fellow of the Australia and New Zealand College of Advanced Pharmacy (FANZCAP) in 2024. These awards underscore his commitment to advancing pharmacy practice, medical education, and health services research. His consistent recognition reflects both academic excellence and sustained contributions to pharmacy education, making him a highly respected educator and clinician in his field.

๐Ÿ”ฌ Research Focus

Dr. Castelinoโ€™s research centers on the quality use of medicines and chronic disease state management, particularly in kidney diseases. He leads a multidisciplinary research group at the University of Sydney dedicated to medication safety and health service improvement in nephrology. His translational research aligns with the Universityโ€™s theme of โ€œBetter Healthโ€ and includes pharmacist-led medication review clinics, studies on metformin use in diabetes, and adverse drug reactions in elderly patients. He has supervised several PhD and MPhil students, with projects targeting medication regimen complexity in end-stage kidney disease and healthcare delivery models. Dr. Castelino’s work is informed by his clinical practice as a renal pharmacist and aims to bridge gaps between patient care and policy implementation. With over 97 publications, including book chapters and professional articles, his research has influenced both academic and hospital-based pharmacy practices. His focus remains on evidence-based interventions that enhance safety and outcomes in vulnerable populations.

โœ… Conclusion

Dr. Ronald Castelino exemplifies the integration of academic excellence, clinical expertise, and research leadership in pharmacy practice. Through his commitment to improving medication safety and chronic disease management, he bridges gaps between education, research, and patient care. His contributions continue to shape pharmacy education and nephrology research in Australia and beyond.

 

Publications

Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda ๐ŸŒŠ, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth ๐Ÿง , renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care ๐Ÿ’ก; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology ๐Ÿฅ, academia ๐Ÿ“š, and public health advocacy ๐Ÿงฌ.

Profile

Education ๐ŸŽ“

Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine ๐ŸŽ“; he earned a B.A. with High Honors in Music from Bowdoin College ๐ŸŽต (1977), pursued advanced coursework at MIT ๐Ÿ›๏ธ, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole ๐Ÿ”ฌ โ€” blending physiology, neurology, and music to form a truly interdisciplinary academic foundation ๐Ÿ“˜.

Experience ๐Ÿ‘จโ€๐Ÿซ

With over three decades in clinical neurology ๐Ÿง , Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013โ€“present) ๐Ÿ‘จโ€๐Ÿซ; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 ๐Ÿฅ, held multiple consultant roles across Vermont and New Hampshire ๐Ÿ—บ๏ธ, and co-directs the Electromyography Lab โšก, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments ๐ŸŒŸ.

Awards & Recognitions ๐Ÿ…

Dr. Stommelโ€™s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award ๐Ÿ† (2011); he is a Fellow of the American Academy of Neurology ๐ŸŽ–๏ธ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology ๐Ÿง , complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education ๐Ÿ“‹๐Ÿ’ก.

Research Interests ๐Ÿ”ฌ

Dr. Stommelโ€™s research revolves around neurodegenerative diseases, especially ALS ๐Ÿงฌ, exploring environmental toxins ๐ŸŒฟ, nanotechnology ๐Ÿงช, and biomarkers ๐Ÿ” to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology ๐Ÿง , he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues ๐ŸŒ๐Ÿ’ก.

Publications